Considerations for Immunology and Immunotoxicology Endpoints in Early Drug Development, Upcoming Webinar Hosted by Xtalks
Retrieved on:
화요일, 4월 6, 2021
TORONTO, Ontario, April 6, 2021 /PRNewswire-PRWeb/ -- There are many considerations for Immunology and Immunotoxicology (I&I) assessments that are needed during the early phase of drug development.
Key Points:
- TORONTO, Ontario, April 6, 2021 /PRNewswire-PRWeb/ -- There are many considerations for Immunology and Immunotoxicology (I&I) assessments that are needed during the early phase of drug development.
- For more information, or to register for this event, visit Considerations for Immunology and Immunotoxicology Endpoints in Early Drug Development .
- Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.
- Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.